ERBB2 and triple-negative breast carcinoma: Additionally, the MCF-10A cells with added mutations begin to model triple-negative breast cancer, since these cells do not express the estrogen receptor (ER) or progesterone receptor (PR), nor do they overexpress Her2/Neu [1].